ODTX (Odyssey Therapeutics, Inc. Common Stock) Stock Analysis - Politician Trades
Odyssey Therapeutics, Inc. Common Stock (ODTX) is a publicly traded the market company. As of May 21, 2026, ODTX trades at $16.98 with a market cap of $820.36M and a P/E ratio of 0.00. ODTX moved +0.35% today. Year to date, ODTX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $15.35 to $20.30. Rallies surfaces ODTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded ODTX stock?
Rallies tracks politician and congressional stock disclosures for ODTX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
TPG GP A, LLC bought 1.39M (~$25.00M) on May 11, 2026.
SR ONE CAPITAL MANAGEMENT, LLC sold 1.06K (~$19.17K) on May 11, 2026.
SR ONE CAPITAL MANAGEMENT, LLC bought 222.22K (~$4.00M) on May 11, 2026.
ODTX Analyst Consensus
ODTX analyst coverage data. Average price target: $0.00.
Common questions about ODTX
Which politicians traded ODTX stock?
Rallies tracks politician and congressional stock disclosures for ODTX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in ODTX?
Yes. Rallies tracks politician and congressional stock disclosures for ODTX, including reported purchases, sales, dates, owners, and trade amounts when available.
Is ODTX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ODTX. It does not provide personalized investment advice.